drugset / Trial / NCT06914206
Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
Not yet recruiting
184 enrolled
Beijing Tiantan Hospital
Beijing Ditan Hospital · collabBeijing Xiaotangshan Hospital · collabHengshui People's Hospital · collabThe First Hospital of Fangshan District,Beijing · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
To assess the 1-month effects and safety of esketamine - PRF -standardized drug treatment against PRF -standardized drug treatment acute/subacute zoster-associated pain (ZAP) patients.
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-04-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | — | Intravenous |